• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 06, 2022 at 11:52: AM
via
  • Pfizer's $6.7 billion acquisition of Arena closed in March and is already bearing fruit.
  • Pfizer recently reported positive results from two phase 3 studies of Arena's etrasimod.
  • Etrasimod has blockbuster potential if approved.

article source
 

<



Similar threads

cafead
Pfizer Just Took Out $31 Billion in Debt. Here&#039;s Why That&#039;s Good News
Replies
0
Views
132
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca&#039;s Blunders
Replies
0
Views
243
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Three Billionaires Behind Pfizer&#039;s Vaccine Partner BioNTech Are $2 Billion Richer...
Replies
0
Views
157
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca steps out from Daiichi&#039;s shadow, posting data on in-house rivals to AbbVie and Pfizer ADCs
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vaxcyte&#039;s &#039;stunning&#039; 31-valent pneumococcal vaccine win against Pfizer&#039;s Prevnar 20 has analysts thinking big
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote